Timing the Implantation of Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy* * Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 47, Issue 12, 2006, Pages 2483-2485

  Marchlinski, Francis E ^a   Jessup, Mariell ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; TROPONIN;

CARDIOMYOPATHY; CARDIOVASCULAR RISK; CHRONOTHERAPY; CLINICAL ASSESSMENT; CLINICAL PRACTICE; DEFIBRILLATOR; DIAGNOSTIC REASONING; DISEASE COURSE; EARLY INTERVENTION; EDITORIAL; EVIDENCE BASED MEDICINE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART PACING; HUMAN; HYPONATREMIA; IMPLANTATION; MEDICAL DECISION MAKING; PARAMETERS OF MEASUREMENT AND ANALYSIS; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; REPRODUCIBILITY; RISK ASSESSMENT; TREATMENT OUTCOME;

CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; HUMANS; PROGNOSIS; TIME FACTORS;

EID: 33744978528     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.01.075     Document Type: Editorial

References (17)

1. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
2. Kadish A., Dyer A., Daubert J.P., et al., Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
3. Kadish A., Schaecter A., Subacius H., et al. Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators. J Am Coll Cardiol 47 (2006) 2477-2482
4. McClellan M., and Tunis S.R. Medicare coverage of ICDs. N Engl J Med 352 (2005) 222-224
5. McCarthy R.E., Boehmer J.P., Hruban R.H., et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342 (2000) 690-695
6. Hsu L., Jais P., Sanders P., et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351 (2004) 2373-2383
7. Yarlagadda R.K., Iwai S., Stein K.M., et al. Reversal of cardiomyopathy in patients with repetitive monomorphic ventricular ectopy originating from the right ventricular outflow tract. Circulation 112 (2005) 1092-1097
8. Wilkoff B.L., Cook J.R., Epstein A.E., et al., Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. the Dual Chamber and VVI Implantable Defibrillator (DAVID) trial. JAMA 288 (2002) 3115-3123
9. Wong M., Staswewsky L., Latini R., et al. Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure. Valsartan Heart Failure Trial (Val-HeFT) echocardiographic data. J Am Coll Cardiol 43 (2004) 2022-2027
10. Sheppard R., Bedi M., Kubota T., et al., IMAC Investigators. Myocardial expression of Fas in patients with recent-onset cardiomyopathy. J Am Coll Cardiol 46 (2005) 1036-1042
11. Hsia H.H., Callans D.J., and Marchlinski F.E. Characterization of the electrophysiologic substrate in patients with non-ischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation 108 (2003) 704-710
12. Marchlinski F.E., Zado E., Dixit S., et al. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation 110 (2004) 2293-2298
13. Nazarian S., Bluemke D.A., Lardee A.C., et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112 (2005) 2821-2825
14. Steimle A.E., Stevenson L.W., Fonarow G.C., MA Hamilton M.A., and Moriguchi J.D. Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol 23 (1994) 553-559
15. Sato Y., Yamada T., Taniguchi R., et al. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 103 (2001) 369-374
16. Naqvi T.S., Goel R.K., Forrester J.S., and Seigel R.J. Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy. J Am Coll Cardiol 34 (1999) 1537-1544
17. Kittleson M., Hurwitz S., Shah M.R., et al. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. J Am Coll Cardiol 41 (2003) 2029-2035